Skip to main content

Table 4 The clinical characteristics of three patient with Niraparib treatment

From: Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer

 

Age

Type

Bilateral ovaries

FIGO

CA125(Before)

CA125(After)

BRCA

Tumor metastasis

Surgery

Chemotherapy

Patient 1

45

HGSC

Yes

IIIC

6.96

7.2

Wild

No

Yes

Yes

Patient 2

58

HGSC

Yes

IV

13.2

12.3

Wild

No

Yes

Yes

Patient 3

60

HGSC

Yes

IV

7.55

11.1

Wild

No

Yes

Yes